You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,669,965


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,669,965
Title: 1-LOWER ALKYL OR ALKYLENE SUBSTITUTED-6,7-METHYLENEDIOXY-4(1H)-OXOCINNOLINE-3-CARBOXYLIC ACIDS AND METHODS FOR MAKING AND USING SAME
Abstract:1-Lower alkyl or alkenyl substituted-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acids, active against Gram-negative bacteria and Mycoplasma organisms and methods for the preparation and use thereof.
Inventor(s): White; William A. (Fountaintown, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:04/888,880
Patent Claim Types:
see list of patent claims
Compound; Use;
Patent landscape, scope, and claims:

United States Patent 3,669,965: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 3,669,965, titled "1-Lower alkyl or alkenyl substituted-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acids and methods for making and using same," was granted to William A. White, an inventor affiliated with Eli Lilly and Company. This patent is significant in the field of pharmaceuticals, particularly for its antimicrobial properties. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Context

The patent was filed on December 29, 1969, and granted on June 13, 1972. It is a continuation-in-part of a previous application, Ser. No. 796,546, which was filed on February 4, 1969, and later abandoned[4].

Scope of the Invention

The patent describes a class of compounds known as 1-lower alkyl or alkenyl substituted-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acids. These compounds are active against Gram-negative bacteria and Mycoplasma organisms, making them valuable in the treatment of various infections.

Chemical Structure and Synthesis

The patent details the chemical structure of these compounds and provides methods for their synthesis. The compounds are characterized by their methylenedioxy and oxocinnoline moieties, which are crucial for their antimicrobial activity[4].

Pharmacological Activity

The invention includes data from experiments demonstrating the efficacy of these compounds against specific microorganisms. For example, the patent describes tests showing the compounds' activity against Gram-negative bacteria and Mycoplasma organisms, highlighting their potential as therapeutic agents[4].

Claims of the Patent

The patent includes 19 claims that define the scope of the invention.

Independent Claims

The independent claims outline the core aspects of the invention, including the chemical structure of the compounds and their use as antimicrobial agents. For instance, Claim 1 describes the general structure of the 1-lower alkyl or alkenyl substituted-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acids[4].

Dependent Claims

The dependent claims provide additional details and variations of the compounds, such as different substituents and methods of preparation. These claims help to further define the scope of the invention and protect various aspects of the compounds and their uses[4].

Patent Landscape

To understand the broader patent landscape, it is essential to consider related patents and the global intellectual property environment.

Related Patents

Other patents in the same field often involve similar chemical structures or methods of synthesis. For example, patents related to methylenedioxybenzene derivatives may share some similarities with the compounds described in US 3,669,965. These related patents can provide insights into the evolution of antimicrobial compounds and the competitive landscape in pharmaceutical research[5].

International Patent Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO), can reveal whether similar inventions have been patented abroad. This is crucial for understanding the global patent landscape and potential infringement risks[1].

Search Tools and Resources

Several tools and resources are available for conducting thorough patent searches.

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art, including patents and published patent applications. This tool can help identify related patents and assess the novelty of the invention described in US 3,669,965[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and related citation data. This can be useful in understanding the international patent landscape and the status of related applications[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for conducting comprehensive patent searches[1].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO can offer insights into the economic and research implications of patents like US 3,669,965. This dataset includes detailed information on claims from U.S. patents and can help in analyzing the scope and impact of the patent[3].

Expiry and Legal Status

The patent has expired, as indicated by its legal status. This means that the invention is now in the public domain, and the compounds and methods described can be used without infringing on the original patent[4].

Conclusion and Key Takeaways

  • Chemical Structure and Synthesis: The patent describes specific compounds with antimicrobial properties and methods for their synthesis.
  • Claims: The patent includes 19 claims that define the scope of the invention, including the chemical structure and use of the compounds.
  • Patent Landscape: Understanding related patents and international databases is crucial for assessing the competitive landscape.
  • Search Tools: Utilizing tools like the USPTO Patent Public Search and Global Dossier can help in conducting thorough patent searches.
  • Economic Implications: The Patent Claims Research Dataset can provide insights into the economic impact of such patents.
  • Legal Status: The patent has expired, placing the invention in the public domain.

FAQs

Q: What is the main subject of United States Patent 3,669,965?

A: The main subject is a class of compounds known as 1-lower alkyl or alkenyl substituted-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acids, which have antimicrobial properties.

Q: Who was the inventor and assignee of this patent?

A: The inventor was William A. White, and the assignee was Eli Lilly and Company.

Q: What is the significance of the methylenedioxy and oxocinnoline moieties in the compounds?

A: These moieties are crucial for the antimicrobial activity of the compounds.

Q: How many claims are included in this patent?

A: The patent includes 19 claims.

Q: What is the current legal status of this patent?

A: The patent has expired, placing the invention in the public domain.

Cited Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US3669965A: https://patents.google.com/patent/US3669965A/en
  5. Google APIs - United States Patent (19): https://patentimages.storage.googleapis.com/5b/bc/a6/c9c75c1bd7fb24/US4082774.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,669,965

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,669,965

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 301541 ⤷  Subscribe
Austria 308747 ⤷  Subscribe
Belgium 745383 ⤷  Subscribe
Brazil 6915225 ⤷  Subscribe
Canada 968354 ⤷  Subscribe
Canada 986111 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.